Anhui Huaheng Biotechnology Co., Ltd. (688639.SS)
CNY 34.06
(-4.0%)
CNY 34.06
(-4.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.93 Billion | 1.41 Billion | 954.09 Million | 487.24 Million | 491.31 Million | 420.84 Million |
| Cost of Revenue | 1.15 Billion | 870.2 Million | 645.63 Million | 275.12 Million | 265.46 Million | 253.73 Million |
| Gross Profit | 782.36 Million | 548.44 Million | 308.45 Million | 212.11 Million | 225.84 Million | 167.11 Million |
| Operating Expenses | 274.4 Million | 218.06 Million | 123.3 Million | 69.56 Million | 76.31 Million | 78.59 Million |
| Selling, General and Administrative Expenses | 157.54 Million | 135.35 Million | 74.68 Million | 33.15 Million | 31.2 Million | 46.01 Million |
| Research and Development Expenses | 108.82 Million | 78.61 Million | 52.84 Million | 30.12 Million | 29.95 Million | 21.72 Million |
| Other Expenses | -2.94 Million | 4.09 Million | -4.22 Million | 6.29 Million | 15.15 Million | 2.08 Million |
| Cost and Expenses | 1.42 Billion | 1.08 Billion | 768.94 Million | 344.69 Million | 341.78 Million | 332.33 Million |
| Operating Income | 510.9 Million | 342.04 Million | 186.34 Million | 132.35 Million | 145.96 Million | 84.46 Million |
| Interest Expense | 13.2 Million | 540.24 Thousand | 1.1 Million | 2.82 Million | 4.04 Million | 4.65 Million |
| Income Tax Expense | 59.67 Million | 23.64 Million | 22.55 Million | 18.83 Million | 19.4 Million | 11.04 Million |
| Earnings before Tax | 506.27 Million | 342.98 Million | 190.78 Million | 139.93 Million | 145.78 Million | 86.54 Million |
| Net Income | 449.06 Million | 320.02 Million | 168.23 Million | 121.1 Million | 126.37 Million | 75.5 Million |
| Earnings Per Share Basic | 1.98 | 1.41 | 0.74 | 0.53 | 0.56 | 0.33 |
| Earnings Per Share Diluted | 1.98 | 1.41 | 0.74 | 0.53 | 0.56 | 0.33 |
| Weighted Average Shares Outstanding | 227.12 Million | 227.07 Million | 226.22 Million | 227.07 Million | 227.07 Million | 227.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 227.12 Million | 227.07 Million | 226.22 Million | 227.07 Million | 227.07 Million | 227.07 Million |
| Gross Margin | 0.40 | 0.39 | 0.32 | 0.44 | 0.46 | 0.40 |
| EBIT Margin | 0.32 | 0.29 | 0.26 | 0.37 | 0.37 | 0.28 |
| Profit Margin | 0.23 | 0.23 | 0.18 | 0.25 | 0.26 | 0.18 |
| EBITDA | 618.3 Million | 403.24 Million | 239.94 Million | 177.8 Million | 183.07 Million | 115.59 Million |
| Earnings Before Tax Margin | 0.26 | 0.24 | 0.20 | 0.27 | 0.30 | 0.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 522.81 Million | 515.43 Million | 498.12 Million | 574.1 Million | 1.93 Billion | 514.27 Million |
| Cost of Revenue | 410.95 Million | 362.48 Million | 332.63 Million | 352.1 Million | 1.15 Billion | 306.76 Million |
| Gross Profit | 111.86 Million | 152.95 Million | 165.48 Million | 222 Million | 785.31 Million | 207.51 Million |
| Operating Expenses | 82.1 Million | 81.71 Million | 70.5 Million | 71.03 Million | 270.5 Million | 64.85 Million |
| Selling, General and Administrative Expenses | 119.31 Million | 9.14 Million | 42.01 Million | 33.64 Million | - | 74.23 Million |
| Research and Development Expenses | 27.16 Million | 34.86 Million | 28.48 Million | 31.51 Million | - | 22.96 Million |
| Other Expenses | -64.36 Million | 727.67 Thousand | 352.56 Thousand | 1.41 Million | -4.63 Million | -534.27 Thousand |
| Cost and Expenses | 493.06 Million | 444.2 Million | 403.13 Million | 423.13 Million | 1.42 Billion | 371.61 Million |
| Operating Income | 19.06 Million | 67.18 Million | 94.98 Million | 142.17 Million | 510.9 Million | 142.06 Million |
| Interest Expense | 10.53 Million | 9.14 Million | 7.44 Million | 5.22 Million | 10.63 Million | 3.27 Million |
| Income Tax Expense | -387.49 Thousand | 5.78 Million | 10.71 Million | 16.38 Million | 59.67 Million | 13.25 Million |
| Earnings before Tax | 19.61 Million | 67.9 Million | 96.58 Million | 143.59 Million | 506.27 Million | 141.53 Million |
| Net Income | 20.18 Million | 63.13 Million | 86.57 Million | 129.11 Million | 449.06 Million | 128.71 Million |
| Earnings Per Share Basic | 0.09 | 0.28 | 0.38 | 0.57 | - | 0.57 |
| Earnings Per Share Diluted | 0.09 | 0.28 | 0.38 | 0.57 | - | 0.57 |
| Weighted Average Shares Outstanding | 227.06 Million | 227.06 Million | 228.43 Million | 227.12 Million | 158.12 Million | 227.59 Million |
| Weighted Average Shares Outstanding (Diluted) | 227.06 Million | 227.06 Million | 228.43 Million | 227.12 Million | 158.12 Million | 227.59 Million |
| Gross Margin | 0.21 | 0.30 | 0.33 | 0.39 | 0.41 | 0.40 |
| EBIT Margin | 0.06 | 0.15 | 0.21 | 0.26 | - | 0.28 |
| Profit Margin | 0.04 | 0.12 | 0.17 | 0.22 | 0.23 | 0.25 |
| EBITDA | 30.14 Million | 77.96 Million | 102.85 Million | 151.15 Million | - | 143.82 Million |
| Earnings Before Tax Margin | 0.04 | 0.13 | 0.19 | 0.25 | 0.26 | 0.28 |
CGEN
300425
SYNGENE
0NNU
300248
CSNVF